Treatment stores

Global Complementary and Alternative Cancer Treatment Market

Brooklyn, New York, May 02, 2022 (GLOBE NEWSWIRE) — According to a new market research report released by Global Market Estimates, the Global Complementary and Alternative Cancer Treatment Market is expected to grow at a CAGR of 21.8% from 2022 to 2027.

The confluence of several factors including improved patient outcomes, increasing evidence of CAM-based cancer care, and rising cancer prevalence is propelling the market growth.

Browse 151 market data tables and 117 figures spread over 189 pages and a detailed table of contents on “Global Complementary and Alternative Cancer Treatment Market – Forecasts until 2027

Key market information

  • From the intervention type perspectives, the health supplement intervention type is expected to be the most revenue-generating segment
  • Based on indication outlook, breast cancer is expected to dominate the complementary and alternative cancer treatment market in 2021 in terms of revenue share
  • The North America market (United States, Canada, and Mexico) is estimated to account for a major share of the global complementary and alternative cancer treatments market revenue from 2022 to 2027
  • Asia-Pacific is expected to be the most revenue-generating market during the forecast period
  • Actors include Akesis Oncology, The Stram Center, ZenHeal Wellness Private Limited, COH HoldCo Inc., Pellegrino Healing Center, Aurora Health Care, Saskatoon Naturopathic Medicine Inc., St. Elizabeth Healthcare, Synthesis Clinic, and Abramson Cancer Center, among others. Complementary and Alternative Cancer Treatments Market Keys

Request a sample copy of the report @

Intervention Type Outlook (Revenue, USD Billion, 2022-2027)

  • Acupuncture or acupressure
  • Reiki or therapeutic/healing touch
  • Yoga
  • Tai Chi or Qigong
  • Hormonal therapies
  • Health supplements
  • Emotional and spiritual healing
  • Others

Indication Outlook (Revenue, USD Billion, 2022-2027)

  • Breast cancer
  • Ovarian cancer
  • Cervical cancer
  • Lung cancer
  • Colorectal cancer
  • Gastrointestinal cancer
  • Others

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America


  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • The rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central and South America

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of MEA